Trials / Unknown
UnknownNCT05515289
Study of SHR6390 in Renal Insufficiency and Healthy Subjects
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
The study is a single-center, open, single-dose, self-controlled clinical trial. It is planned to enroll 24-30 subjects. Subjects will take the SHR6390 on Day1.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SHR6390 | SHR6390 tablet single dose, and subjects will take the SHR6390 on Day 1. |
Timeline
- Start date
- 2022-12-18
- Primary completion
- 2023-08-28
- Completion
- 2023-09-28
- First posted
- 2022-08-25
- Last updated
- 2023-03-10
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05515289. Inclusion in this directory is not an endorsement.